Literature DB >> 12034368

Induction of glutathione-S-transferase mRNA levels by chemopreventive selenocysteine Se-conjugates.

Peter A C 't Hoen1, Martijn Rooseboom, Martin K Bijsterbosch, Theo J C van Berkel, Nico P E Vermeulen, Jan N M Commandeur.   

Abstract

Several selenocysteine Se-conjugates (SeCys-conjugates) prevent against chemically induced carcinogenesis. Bioactivation to selenols (RSeH) by beta-lyases is thought to be critical, but the mechanism of tumor suppression remains unclear. Induction of phase II biotransformation enzymes is a possible mechanism of chemoprevention. In this study, we evaluated the isoform-selective induction of glutathione-S-transferase (GST) at the mRNA level using a quantitative reverse transcriptase polymerase chain reaction assay. In cultured primary rat hepatocytes and H35 Reuber rat hepatoma cells, SeCys-conjugates time-dependently increased mRNA levels of GST Alpha isoforms and GST Pi, but not of GST Mu isoforms. Se-allyl-L-selenocysteine, the most potent chemopreventive SeCys-conjugate so far known, was also the most active GST inducer. After exposure for 24hr, it elevated GSTA2, GSTA3, GSTA5, and GSTP mRNA levels in primary hepatocytes 3.2+/-0.4-, 1.9+/-0.1-, 4.3+/-0.3-, and 2.9+/-0.3-fold, respectively. Se-allyl-D-selenocysteine was significantly less active, suggesting that stereoselective conversion of SeCys-conjugates to selenols is involved in GST induction. In H35 Reuber hepatoma cells, where conversion of SeCys-conjugates to selenols was 2-6-fold lower than in primary hepatocytes, GST induction was also much lower than in primary hepatocytes. SeCys-conjugates did not induce cytochrome P450 1A1, 2B1/2, or 3A1. This indicates that SeCys-conjugates are monofunctional inducers of phase II biotransformation enzymes. The present results suggest that induction of GST expression contributes to the chemopreventive activity of SeCys-conjugates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034368     DOI: 10.1016/s0006-2952(02)00987-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Nrf2 target genes are induced under marginal selenium-deficiency.

Authors:  Mike Müller; Antje Banning; Regina Brigelius-Flohé; Anna Kipp
Journal:  Genes Nutr       Date:  2010-01-29       Impact factor: 5.523

2.  Murine hepatoma (Hepa1c1c7) cells: a responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds.

Authors:  Wael M El-Sayed; Tarek Aboul-Fadl; Jeanette C Roberts; John G Lamb; Michael R Franklin
Journal:  Toxicol In Vitro       Date:  2006-10-07       Impact factor: 3.500

3.  Selenite transiently represses transcription of photosynthesis-related genes in potato leaves.

Authors:  Valeria Poggi; Valerio Del Vescovo; Claudio Di Sanza; Rodolfo Negri; Alejandro Hochkoeppler
Journal:  Photosynth Res       Date:  2007-09-11       Impact factor: 3.573

4.  Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.

Authors:  Nong Xiang; Rui Zhao; Guoqing Song; Weixiong Zhong
Journal:  Carcinogenesis       Date:  2008-08-01       Impact factor: 4.944

5.  Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke.

Authors:  Daniel J Conklin; Petra Haberzettl; Russell A Prough; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-06       Impact factor: 4.733

6.  Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.

Authors:  Daniel J Conklin; Petra Haberzettl; Jean-Francois Lesgards; Russell A Prough; Sanjay Srivastava; Aruni Bhatnagar
Journal:  J Pharmacol Exp Ther       Date:  2009-08-20       Impact factor: 4.030

7.  Impact of heat treatment on size, structure, and bioactivity of elemental selenium nanoparticles.

Authors:  Jinsong Zhang; Ethan W Taylor; Xiaochun Wan; Dungeng Peng
Journal:  Int J Nanomedicine       Date:  2012-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.